Risk factors predisposing to psychotic symptoms during levetiracetam therapy: A retrospective study

Florentina M. E. Pinckaers*, Mebeline E. Boon, Marian H. J. M. Majoie

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number106344
Number of pages7
JournalEpilepsy & Behavior
Volume100
DOIs
Publication statusPublished - Nov 2019

Keywords

  • Epilepsy
  • Psychotic symptoms
  • Psychosis
  • Levetiracetam
  • AIPD
  • PSYCHIATRIC ADVERSE EVENTS
  • ANTIEPILEPTIC DRUGS
  • ILAE COMMISSION
  • EPILEPSY
  • DISORDERS
  • ADULTS

Cite this